Use access key #2 to skip to page content.
$2.41 0.02 (0.84%)
7/3/2008 1:00 PM

Cell Genesys, Inc. (CEGE)

CAPS Rating:
***

A biotechnology company focused on the development and commercialization of novel biological therapies for patients with cancer.

View All Commentary (CEGE)

Recs

1

Avatar mamicro (98.61) Submitted: 10/17/07 3:54 PM : Underperform Start Price: $3.63 CEGE Score: 15.63

It needs some good news to break out. The trials are't far enough along.

Report this Post Replies: 0 | Reply

Featured Broker Partners